Fodor, George

Overview 

Dr. George Fodor is Head of Research for the Minto Prevention and Rehabilitation Centre at the University of Ottawa Heart Institute, Professor Emeritus of Medicine and Clinical Epidemiology at Memorial University of Newfoundland, and Professor at the University of Ottawa. His experience has made him a leading Canadian expert in the area of preventive cardiology.

Background 

Dr. George Fodor graduated with a degree in Medicine from Charles University in Prague. He obtained his PhD from the Czech Academy of Science, and trained in cardiology at the Institute of Cardiovascular Research (Prague).

Dr. Fodor has been the Principal Investigator of the following: “Heart Healthy Nutrition in Hungary,” a study funded by the World Bank; “Cardiovascular Health Care Telelink Project in Hungary,” a study funded by the Canadian International Development Agency; and “Women’s Heart Health and the Work Site” and “Cardiovascular Prevention at a Canadian Work Site,” two industrially funded studies.

He is presently coordinating a number of projects in Central and Eastern Europe in co-operation with McMaster University in Hamilton, Ontario, and conducting a study of Metabolic syndrome in three areas of Newfoundland, in cooperation with the Memorial University of Newfoundland.

Dr. Fodor is the Founding President of the Canadian Hypertension Society and the Canadian Coalition for Hypertension Prevention and Control. He has received the National Health Scientist Award from Health Canada, a Distinguished Scientist Award of the Canadian Hypertension Society, and the Segal Award for Merit in Cardiovascular Disease Prevention from the Canadian Cardiovascular Society.

Dr. Fodor has over 200 publications to his name.

Research & Clinical Interests 

Dr. Fodor’s main areas of research are the epidemiology of ischemic heart disease, arterial hypertension , lipid metabolism and atherosclerosis , and primary and secondary prevention of coronary heart disease.

Publications 

LATEST PUBLICATIONS

  • McInnis NH, Fodor G, Moy Lum-Kwong M, Leenen FH. Antihypertensive medication use and blood pressure control: a community-based cross-sectional survey (ON-BP). Am J Hypertens 2008 September 4 (in press).
  • Myers Mg, McInnis NH, Fodor GJ, Leenen FH. Response to “automated sphygmomanometers should not replace manual ones, based on current evidence.” Am J Hypertens 2008 Aug;21(8):846.
  • Fodor GJ, Leenen FHH, Helis E, Turton P. Ontario survey on the prevalence and control of hypertension, 2006 (ON-BP): rationale and design of a community-based cross-sectional survey. Can J Cardiol 2008 June;24(6):503-505.
  • Fodor G. Abdominal obesity: a physician’s "supertool" for accessing CVD risk. Patient Care Cardiology (Medical Post); June 24, 2008.
  • Leenen FHH, Dumais j, McInnis NH, Turton P, Stratychuk L, Nemeth K, Moy Lum-Kwong M, Fodor G. Results of the Ontario survey on the prevalence and control of hypertension. CMAJ 2008 May;178(11):1441-1449.

PAPERS IN REFEREED JOURNALS

  • Gal T, Reichl D, Kubic G and FODOR, JG: Vessel Wall Proteins (in Czech.). Chem 48:l873, l954.
  • Zemplenyi T, Felt V, FODOR JG, Reichl D and Pilar J: Heparin and the Clearing Reaction in Atherosclerosis (in Czech.). Cas. Lek. Ceskych 94:262-266, l955.
  • FODOR JG and Lojda Z: The Relation of Mast Cells to the Lipid Transport (in Czech) Cs. Fysiologie 5:288-294, l956.
  • FODOR JG, Fabry, P and Lojda Z: High Fat Diet and Mast Cell Count in Rat Mesenterium. Experientia l4:l84, l958.
  • Fabry J, Petrasek R and FODOR JG: Der Respirationsquotient bei mit fett-und cholesterinreicher. Diat gefutterten Ratten Naturwissenschaften 45:444-445, l958.
  • FODOR JG, Zemplenyi T, Lojda Z and Felt V: The Influence of Heparin and Protaminsulphate on Experimental Atherosclerosis in Rabbits (in Czech.). Cas. Lek. Ceskych 97:3l6-3l9, l958.
  • Lojda Z, and FODOR JG: Cytochemical Study of the Mast Cells of Rat Mesenterium. Cs Morfolgie 68l-685, l958 (Czechoslovakia).
  • Viktora J, FODOR JG, Grafnetter G, Hahn P, Koldovsky, O and Lojda, Z: Observation of Changes in Lipid Metabolism During the Ontogenesis of Rat (in Czech.). Cs. Fysiologie 9:93-94, l960.
  • FODOR JG, Fabry P and Lojda Z: Der Einfluss langfristiger Verabreichung von Diaten mit hohem Fettgehalt auf die Anzahl der Mastzellen im. Mesenterium von Ratten Virchows' Arch Path Anat 333:582-586, l960.
  • Zemplenyi T, FODOR JG and Lojda Z: Mast Cell Histamine & the Accumulation of Colloid Particles in the Vascular Endothelium. Q J Exp Physiol 45:50-53, l960.
  • FODOR JG and Grafnetter D: The Influence of Thiopentone Anesthesia on the Blood Lipid and Blood Sugar Level. Brit. J. Pharmacol. Chemother. l5:282-285, l960.
  • FODOR JG, Felt V and Vavrik M: A Contribution to the Problem of Epidemiology of Coronary Heart Disease (in Russian). Contemporary Problems of Cardiology Medgiz, Moscow pp. 275-282, l960.
  • FODOR JG, Zemplenhi T, Lojda Z and Fabry P: Mast Cells and Fat Metabolism Proceedings of the 5th National Congress of the Czech Physiological Society, Karolvy. Vary, pp 76-77, l96l.
  • FODOR JG, Kohout M, Pazlar M, Reichl, D and Zemplenyi T: The Effect of the Long Term Application of Protaminsulphate on the Lipid Metabolism in Rats (in Czech.). Cs. Fysiologie ll:439-440, l962.
  • Fabry P, Braun T, Petrasek R, Frankova S, Masek J and FODOR JG: Some Effects of High Fat Diet on Animal Experiments (in Czech.). Cs. Gastroenterologie l6:l78-l82, l962.
  • FODOR JG, Hladovec J and Mansfield V: Report about the Research in Problems on Atherosclerosis and Metabolism in USSR (in Czech.). Cs. Fysiologie ll:l44-l50, l962.
  • FODOR JG, Zemplenyi T, Lojda Z and Fabry P: The Role of Mast Cells in Lipid Metabolism. Rev Czechoslov Med 8:l33-l36, l962.
  • FODOR JG, Mrhova O and Zemplenyi T: Metabolism of Fatty Acids and Glucose in Myocardium of Rats Under the Influence of Thiopentone Anesthesia (in Czech.). Cs Fysiologie ll:233-234, l962.
  • FODOR JG, Miall WE, Standard KL, Fejfar Z and Stuart KL: Myocardial Disease in a Rural Population in Jamaica. Bull. Wld. Health Oerg. 3l:32l-335, l964.
  • Fabry P, FODOR JG, Hejl Z, Braun T and Zvolankova K: The Frequency of Meals: Its Relation of Overweight, Hypercholesterolemia and Decreased Glucose Tolerance. Lancet 2:6l4-615, l964.
  • FODOR JG: Problems of the Epidemiology of Cardiovascular Diseases. Fourth European Cardiological Congress in Prague. August l6-23, l964 J Hyg Epid Microb Immunol 9:ll9, l965.
  • FODOR JG, Hejl Z, Kohout M, Santrucek M, Vavrik, M and Weber K: The Prevalence of Ischemic Heart Disease and the Distribution of Blood Pressure in a Population Sample of Males Ages 60-64 Years in a City District of Prague. ll Giornale dell Arteriosclerosi 4:l52-l64, l966.
  • Grafnetter D, Hofman J, FODOR JG, Hejl Z and Kohout M: Serum Cholesterol Levels in Rural and Urban Populations: Its Relation to Body Build, Physical Activity and Ischemic Heart Disease. ll Giornale dell Arterioclerosi 4:l73-l76, l966.
  • Kafka H, FODOR JG, Hejl Z, Kohout M and Vrobova D: Investigations at the Elastic Properties of Crural Arteries in population Groups of Men Ages 60-64 Years (in Czech.). Sbnornik Lekarsky 68:3l0-3l4, l966.
  • Stanek V, FODOR JG, Hejl Z, Charvat P, Santrucek M, Widimsky J, and Zajic F: A Contribution to the Epidemiology of Chronic Bronchitis Acta Med. Scand. l79:737-746, l966.
  • Grafnetter D, FODOR JG, Ceply V and Zacek K: The Effect of Storage on Levels of Cholesterol in Serum as Measured by a Simple Direct Method. Clin. Chem. Acta l6:33-37, l967.
  • FODOR JG: Epidemiologie der Ischamischem Herzkrankheit. Zschr. arztl. Fortbld. 6l:865-868, l967.
  • FODOR JG: Epidemiology of Cardiovascular Diseases (in Czech.). Cs Fysiol l6:338-342, l967.
  • FODOR JG, Hejl Z, Santrucek M, Vavrik D, Vrobova, D and Weber K: The Prevalence of Ischemic Heart Disease and Obliterative Atherosclerosis of Peripheral Arteries in 60-64 Year Old Males of a City Population. Cor Vasa l0:4l-47, l968.
  • FODOR JG: Screening for Ischemic Heart Disease Chapter in the Book "Early and Pre-asymptomatic Diagnosis". Edited by Sharp, CC and Keen, Harry, Pitman Med. Publ. London, 99:283-293, l968.
  • Fabry P, FODOR JG, Hejl Z, Geizerova H and Balcaroba O: Meal Frequency and Ischemic Heart Disease. Lancet l:l90-l9l, l968.
  • FODOR JG: The Ischemic Heart Disease Register in Goteborg. Pehr Dubb Journalen 3:26-33, l969.
  • FODOR JG, Hejl Z and Madar J: Pragstudien (in Swedish). Lakartidningen 67:l50-l52, l970.
  • Pfeiffer CJ, FODOR JG and Geizerova H: An Epidemiologic Study of the Relationship of Peptic Ulcer Disease in 50-54 Year Old, Urban Males with Physical, Health and Smoking Factors. J Chron Dis 26:29l-302, l973.
  • Miall WE, Del Campo E, FODOR JG, Nova Rhode JR, Ruiz L, Standard KL & Swan AV: Longitudinal Study of Heart Disease in a Jamaican Rural Population 1. Prevalence, with a special reference to ECG findings. Bull World Health Org 46:429-442, l972.
  • Miall WE, Del Campo E, FODOR JG, Nova Rhode JR, Ruiz L, Standard KL and Swan AV: Longitudinal Study of Heart Disease in a Jamaican Rural Population 2. Factors influencing mortality. Bull World Health Org 46:685-694, l972.
  • Miall, WE, Del Campo E, FODOR JG, Nova Rhode, HR, Ruiz L and Standard KL: Longitudinal Study of Heart Disease in a Jamaican Rural Population 3. Factors influencing changes in serial electrocardiograms. Bull World Health Org 46:695-708, l972.
  • FODOR JG, Pfeiffer CJ and Papezik VS: Relationship of Drinking Water Quality (Hardness-Softness) to Cardiovascular Mortality in Newfoundland. CMAJ l08:l365-l368, l973.
  • Pfeiffer CJ, FODOR JG and Canning E: An Epidemiologic Analysis of Mortality and Gastric Cancer in Newfoundland. CMAJ l08:l374-l380, l973.
  • FODOR JG, Abbott EC and Rusted IE: An Epidemiological Study of Hypertension in Newfoundland. CMAJ l08:l365-l368, l973.
  • FODOR JG, Allderdice WH and Gerson LW: A Method for the Determination of High Blood Pressure Clusters - Paper presented at the Canadian Public Health Association Meeting, June 20, l974.
  • Buehler SK, FODOR JG, Marshall WH, Firme F, Fraser CF and Vaze P: Common Variable Immunodeficiency, Hodgkin's Disease and Other Malignancies in a Newfoundland Family. Lancet l:l95-l97, l975.
  • Gerson LW and FODOR JG: Family Aggregation of High Blood Pressure Groups in Two Newfoundland Communities. Can J Publ Hlth 66:294-298, l976.
  • FODOR JG and Gerson LW: Relation Between Subjective Stress Rating and EKG Changes in Healthy Adults. IRCS Med Sci 3:347, l975.
  • Howe GT, Bruch JD, Miller AB, Morrison B, Gordon P, Weldon L, Chambers, LW, FODOR JG and Winsor GM: Artificial Sweeteners and Human Bladder Cancer. Lancet 2:578-58l, l977.
  • FODOR JG and Bruce-Lockhart, PL: An Innovative Program of Hypertension Management in Primary Care Practices. Canad J Publ Hlth 69:2l-23, l978.
  • Churchill D, Bryant D, FODOR JG and Gault, MH: Drinking Water Hardness and Urolithiasis. Ann Intern Med 88:5l3-5l4, l978.
  • FODOR JG and Bruce-Lockhart PL: The Pharmacist's Role in Community Control of Hypertension. Canad Pharmac J May:l7l-l73, l978.
  • Balram BC and FODOR JG: An Epidemiological Study of Blood Pressure Levels in Children and Adolescents in a Rural Newfoundland Community. IRCS Med Sci 6:363, l978.
  • Oliver MF, Heady JA, Morris JN, Cooper J, Geizerova H, FODOR JG, Gyarfas I, Lamm G, Green KG and Strasser T: Report from the Committee of Principal Investigators - A Cooperative Trial in the Primary Prevention of Ischemic Heart Disease Using Clofibrate. Brit Heart J 40:l069-lll8, l978.
  • Tweeddale MG and FODOR JG: Elevated Serum Uric Acid - A Cardiovascular Risk Factor? Nephron 23:3-6, l979.
  • FODOR JG and Tweeddale MG: Uric Acid, Hypertension and Ischemic Heart Disease. Mod Med Canada 34:569-572, l979.
  • Tweeddale, MG and FODOR JG: An Examination of Elevated Serum Uric Acid in Cardiovascular Disease. Post-Grad Med Suppl May l979.
  • FODOR JG: Influence of Sodium Intake on Hypertension Incidence in Newfoundland. Ann Roy Coll Phys Surg Can October:269-272, l979.
  • Pfeiffer CJ and FODOR JG: Gastric Cancer Mortality and Water Trace Elements: International Study of Iceland, Newfoundland and Japan. Chapter in book entitled "Gastric Cancer - Etiology and Pathogenesis" 45059 ed. by CJ Pfeiffer, Gerhard Witzrock, l979.
  • Tweeddale MG and FODOR JG: Proposal for a Prospective Study on the Role of Uric Acid as a Risk Factor Paper given at Symposium on Hypertension - A Cardiovascular Risk Factor - Milan, Italy, September l979.
  • Hoenig J, FODOR JG and Bhide B: Untreated Psychiatric Morbidity in the Community. Paper given at the Annual Meeting of the Canadian Psychiatric Association - Vancouver, BC September l979.
  • Churchill DN, Maloney C, Black D, FODOR JG and Gault MH: Urolithiasis in Newfoundland - Epidemiological and Clinical Features. Ann Roy Coll Phys Surg Can l2:84, l979.
  • Churchill DN, Maloney C, FODOR JG and Gault MH: Urolithiasis (U): Environmental and Genetic Factors. Ann Roy Coll Phys Surg Can l2:85, l979.
  • Heyden S and FODOR JG: Industrial Cancer Education and Screening for l9,000 Cannon Mill Employees - Hazard. Mat Managem J l:35-4l, l980.
  • Churchill DN, Maloney C, Bear JC, Bryant D, Gault MH and FODOR JG: Urolithiasis - A Study of Drinking Water Hardness and Genetic Factors. J Chron Dis 33:727-73l, l980.
  • FODOR JG and Rusted IE: Epidemiological Studies of Hypertension in Newfoundland Chapter in book entitled "Epidemiology of Arterial Blood
  • Pressure". Eds. Kesteloot and Joossens, Developments in Cardiovascular Medicine, Vol. 8, Martinus Nijhoff, The Hague l980.
  • Howe GR, Burch JG, Miller AB, Cook GM, Esteve J, Morrison R, Gordon P, Chambers LW, FODOR JG and Winsor GM: Tobacco Use, Occupation, Coffee, Various Nutrients and Bladder Cancer. JNCI 64:70l-73l, l980.
  • FODOR JG:. Epidemiology of Hypertension Medicine - North America l:l-4, l980.
  • FODOR JG and Bruce-Lockhart PL: Epidemiology of Coronary Heart Disease Medicine - North America 4:379-389, l980.
  • Vedin JA, Wilhelmsson, CE and FODOR JG: Pathogenesis of Lethal Arrhythmias Chapter in book entitled "Cardiac Ischemic and Arrhythmias". Ed: Amsterdam EA, Symposia Specialists Inc. Chicago, l980.
  • Balram BC and FODOR JG: Electrocardiographic P and R Wave Amplitudes as Determinants of Blood Pressure Levels in Children and Adolescents. IRCS Med Sci 8:722, l980.
  • FODOR JG: Hypertension in Canada: An Update. Chron Dis in Canada l:8-9, l980.
  • Heyden S and FODOR JG: Industrial Cancer Education and Screening for l9,000 Cannon Mill Employees. J Chron Dis 34:225-23l, l98l.
  • Balram BC and FODOR JG: Prevalence of Coronary Heart Disease Risk Factors in Children Living in High versus Low CHD Mortality Regions Atherosclerosis VI Proceedings of the 6th International Symposium, Edited by G. Schettler, Springer Verlag, New York Heidelberg, Germany.
  • Balram BC and FODOR JG: Prevalence of CHD Risk Factors in Children Living in High and Low CHD Mortality Areas. Congr Bull 6th Internat Symp Atherosclerosis - June l982, pages 2-3.
  • Heyden S and FODOR JG: Epidemiology Chapter in the Book: Health Promotion: Principles and Clinical Applications pp. l9-4l (eds. Taylor RB) Appleton-Century-Crofts/Norwalk, Connecticut, l982.
  • Hoenig J and FODOR JG: Untreated Depression in a Working Population. Internat J Soc Psych 28:l29-l36, l982.
  • FODOR JG: Mild Hypertension: Should it be Treated. Can Fam Physic 3l:303-304, l985.
  • Heyden S, Schneider K and FODOR JG: Comprehensive Health Care and Noncardiovascular Mortality: An Unlikely Explanation of the Findings from the Hypertension Detection and Follow-up Program. Circulation 72:692-696, l985.
  • Heyden S and FODOR JG: The Potential Role of Potassium in Blood Pressure Control. Heartbeat l, March l985.
  • Risch HA, Jain M, Choi NW, FODOR JG, Pfeiffer CJ, Howe GR, Harrison LW, Craib KJP, Miller AB. Dietary Factors and the Incidence of the Stomach. Am J Epidem l22:947-959, l985.
  • Heyden S and FODOR JG: Prevention of Fatal and Nonfatal Ischemic Heart Disease by Early Treatment of Hypertension. Cardiology 72(S1):l82-l86, l985.
  • FODOR JG and Heyden S: Public Health and Mild Hypertension: Recent Advances and Future Challenges. Canad J Publ Hlth 77:l7-l8, l986.
  • Heyden S and FODOR JG: Coffee Consumption and Fibrocystic Breasts: An Unlikely Association. Canad J Surg 29:208-2ll, l986.
  • FODOR JG and Heyden S: Diet and High Blood Pressure Chapter in Book "How to Control Your Blood Pressure and Get More Out of Life". Grosvenor House Press Inc., Toronto l986.
  • Heyden S. Schneider KA and FODOR JG: Cholesterol, Hypertension and Coronary Heart Disease. Heartbeat, J Internat Soc Fed Cardiol l:4-5, l986.
  • Heyden S, FODOR JG and Schneider KA: Trends in Arteriosclerosis in Treated and Untreated Hypertensive Patients In the book "Primary Hypertension" eds. Kaufmann et al. Springer - Verlag, Berlin, Heidelberg l986.
  • FODOR JG, Heyden S, Chockalingam A, Logan AG, Hames CG, Klaue and Jenrich A: The P-wave in the ECG of Hypertensive Patients Before and After Therapy. Canad J Card 2:264-67, l986.
  • Chockalingam A, FODOR JG, Heyden S and Zidek W: Changes in Intracellular Electrolytes in Hypertension Proceedings of the Annual Meeting, Canadian Society of Clinical Investigation, Toronto, Ontario September 20-22, l986.
  • Heyden S, Schneider KA, Ruh J and FODOR JG: Habitual Coffee Consumption and Cholesterol Levels. Heartbeat No 3:l-4, l986.
  • FODOR JG: Antihypertensive Agents and Cardiovascular Risk Factors. Clin Therapeut 8:490-509, l986.
  • FODOR JG, Chockalingam A and Ofner, P: Nutrition Sense or Nonsense. Postgrad Med 8l:36-38, l987.
  • FODOR JG, Balram BC and Heyden S: Lipid and Lipoprotein Levels of Newfoundland School Children. Ann Nutr Metab 3l:23l-236, l987.
  • Roberts PM, FODOR JG, Tibblin G and Wilhelmsen L: A Study of the Association Between the Prolongation of the QT Interval in the Resting ECG and Myocardial Infarction. Acta Med Scand 220:395-400, l986.
  • Thelle DS, Heyden S and FODOR JG: Coffee and Cholesterol in Epidemiological and Experimental Studies. Atherosclerosis 67:97-103, 1987.
  • Heyden S, Schneider KA, and FODOR JG: Failure to Reduce Cholesterol as Explanation for the Limited Efficacy of Antihypertensive Treatment in the Reduction of CHD. Klin Wochenschr 65:828-832, 1987.
  • Heyden S, Schneider DA, and FODOR JG: Smoking Habits and Antihypertensive Treatment. Nephron 47(Sl):99-103, 1987.
  • FODOR JG, Chockalingam A, Drover A, Fifield F, Pauls CJ: A Comparison of the Side Effects of Atenolol and Propranolol in the Treatment of Patients with Hypertension . J Clin Pharmacol 27:892-901, 1987.
  • Heyden S, and FODOR JG: Does Regular Exercise Prolong Life Expectancy? Sports Med 6:63-71, 1988.
  • Hunter DJ, Kazda I, Chockalingam A and FODOR JG: Fish Consumption and Cardiovascular Mortality in Canada. Am J Prev Med 4:5-10, 1988.
  • Wolf HK, Dagenais GR, FODOR JG, Fynes RS, Handa SP, Haynes RB, Klassen GA, Myers MG, and Robitaille NM: Blood Pressure Profile in Two Adult Male Populations. CMAJ 139:507-512, 1988.
  • Heyden S, Schneider KA, FODOR JG: Coronary Heart Disease in Hypertensives: A Need to ReduceCholesterol. Int J Epidemiol 17:784-788, 1988.
  • FODOR JG: Hypertension and Hypercholesterolemia as Risks for Coronary Heart Disease. Cardiovascular Focus 3:1-2, 1989.
  • Heyden S, Schneider K.A., FODOR JG: Diabetes Continues to Pose High Risk for Ischemic Heart Disease - Lipid andLipoprotein Abnormalities in Diabetic Patients. Arztl Lab (Intern Med) 35:183-188, 1989.
  • FODOR JG: Patterns of Hypertension and their Implications for Therapy. Can Fam Physician 35:2069-2072, 1989.
  • Heyden S, Schneider K.A., FODOR JG: Diabetes Continues to be a High Risk for Ischemic Heart Disease. Heart Beat, J Internat Soc Fed Cardiol 4:1-2, 1989.
  • FODOR, J.G., and Chockalingam, A.: The Canadian Consensus Report on Non-Phamacological Approaches to the Management of High Blood Pressure. Clin and Exper Hyper - Theory and Practice, A12(5), 729-743, 1990.
  • FODOR, J.G., and Cifkova, R.: Prevalence of Hypertension in Canada. Medicine North America 7:753-758, 1990.
  • Campbell NRC, Chockalingam A, FODOR JG, McKay DW: Accurate Reproducible Measurement of Blood Pressure - A review article. Can Med Asso J 143(1):19-22, 1990.
  • Chockalingam A and FODOR JG: Cardiovascular Risk Factors in Newfoundland Population and Modification of their Level through Nonpharmacological Intervention. J Cardiovasc Pharm 163 (S8): S54-56, 1990.
  • FODOR JG, Chockalingam A, Cifkova R, Strong HA, Cobby J and Mukerjee J: Efficacy of Once Daily Nitrendipine in Mild Hypertension: Comparison with Placebo. Can J Cardiology 7:223-228, 1990.
  • FODOR JG and Chockalingam A: Modification of Cardiovascular Risk Factors in Rural Population of Newfoundland through Nutritional Counselling. Cor et Vasa 33:107, 1991.
  • McKay DW, Campbell NRC, Parab S, Chockalingam A, FODOR JG: Clinical Assessment of Blood Pressure. J. Human Hypertens 4:639-645, 1990.
  • Funke E, Schieffer B, Baikie M, Mohacsi G, Kirkland C, FODOR JG, Chockalingam A: Intersalt in Newfoundland and Labrador. Annals of Nutrition and Metabolism 34:253-258, 1990.
  • Worrall G, FODOR G, Butt M: A Minimal Prevalence Study of Diagnosed Diabetes in Newfoundland and Labrador. Canadian J Public Health 82:104-108, 1991.
  • FODOR GJ and Chockalingam A: Treatment of Mild Hypertension. J Cardiovascular Pharmacology 18:S25-9, 1991.
  • Lloyd OL, FODOR JG, Lloyd MM, Chockalingam A: The Geography of the Community Sex Ratios for Young Children in Newfoundland. Science of Total Environment 106:165-174, 1991.
  • Boulet AP, Chockalingam A, FODOR G, Laplante L, Houde M, Lenis J, Logan AG, Robitaille MN, Ryan D and Spanard J: Treatment of Mild-to-Moderate Hypertension: Comparison Between a Calcium Channel Blocker and a Potassium-Sparing Diuretic. J Cardiovascular Pharmacology 18(Suppl. 9):S45-S50, 1991.
  • Chockalingam A, Robitaille MN, Annable L, FODOR G, Laplante L, Lenis J, Logan A, Houde M, Ryan D, Sp_nard J, and Boulet AP: Diltiazem and Hydrochlorothiazide/Triamterene as Initial Therapy for Mild to Moderate Essential Hypertension. Drug Invest 4(2):173-183, 1992.
  • Joffres MR, Hamet P, Rabkin SW, Gelskey D, Hogan K, FODOR G: Prevalence, Control and Awareness of High Blood Pressure Among Canadian Adults. Can Med Assoc J 146(11): 1997-2005, 1992.
  • FODOR JG: Social and Economic Influences on the Outcome of Coronary Artery Disease. CP Journal Club: 89, 1992.
  • FODOR G: Clinical Management Review: Hypertension - The Role of Calcium Channel Blockers. Medifacts: Vol. XXII, No. 6, 1992.
  • FODOR JG: Canadian Consensus on Hypertension. Canadian Therapeutics: Vol. 1. No. 1, March 1993.
  • Chockalingam A, FODOR JG, Riman T, Cifkova R, Gondos G, Pandian SN, Suhale AS. A controlled community trial of the effectiveness and impact of a preventive cardiovascular health unit on cardiovascular risk in Newfoundland. Can J Cardiol 9(Suppl.D):14D-16D, 1993.
  • FODOR JG, Chockalingam A, Riman T, Cifkova R, Gondos G, Pandian SN, Suhale AS. Prevalence of Cardiovascular Risk Factors in random sample of population in rural Newfoundland. Can J Cardiol 9(Suppl. D):33D-35D, 1993.
  • Chockalingam A, FODOR JG, Reddy S, Cifkova R, Pandian SN, Rastogi S, Suhale AS. Association between fasting plasma insulin (FPI) and cardiovascular risk factors (CVRFs). Can J Cardiology 9(Suppl. D):94D-96D, 1993.
  • Chockalingam A, Rastogi S, Reddy S, Pandian SN, FODOR JG, Cifkova R. Insulin Resistance in Essential Hypertension: Examination of Erythrocye Insulin Receptions. Can J Cardiol 9 (Suppl. D): 96D-98D, 1993.
  • Chockalingam A, FODOR JG, Yamori Y. Cardiovascular risk factors in Newfoundland: Inhabitatns with highest average of blood pressure (BP) among all CARDIAC population. Ca J Cardiol 9(Suppl. D): 33D-35D, 1993.v
  • McKay DW, Campbell NRC, Chockalingam A, FODOR JG. Skills in blood pressure measurement and physician characteristics. Can J Cardiol 9 (Suppl. D):116D-118D, 1993.
  • FODOR JG. Hypertension control: Historic perspectives - 25 years of progress in Canada and around the world. Canadian Journal of Public Health 85(Suppl 2):S7-S8, 1994.
  • Campbell NRC, McKay DW, Chockalingam A, FODOR JG. Errors in Assessment of blood pressure: Patient factors. Canadian Journal of Public Health 85(Suppl 2):S12-S17, 1994.
  • FODOR JG. Dietary sodium restriction in the management of hypertension - the Canadian experience. Nieren-und Hochdruck-krankheiten 23(Suppl 1):S48-9, 1994.
  • FODOR JG. How do we address mild hypertension. Perspectives in Cardiology 11(6):1-2, 1995.
  • FODOR JG, LeGrand CM. Prevention of Coronary Heart Disease. Noninvas Cardiol 5(4):167-70, 1996.
  • FODOR JG. Primary prevention of Cardiovascular disease: Chipping away at the risk. Perspectives in Cardiology 12(9):23-34, 1996.
  • FODOR JG, LeGrand C. Hypertension & Atherosclerosis. Cardiol 6(1):S5-6, 1997.
  • FODOR JG. What are the diagnostic considerations of Hypercholesterolemia? The Canadian Journal of Diagnosis. March issue. pages 1-5, 1997.
  • FODOR JG. Nisoldipine CC: Efficacy and tolerability in hypertension and ischemic heart disease. Cardiovascular Drugs and Therapy 10:873-9, 1997.
  • Ruddy TD, FODOR JG. Nisoldipine-CC and lisinopril alone or in combination for treatment of mild to moderate systemic hypertension. Cardiovascular Drugs and Therapy 11:581-90, 1997.
  • FODOR JG. Comparative efficacy and tolerability of once daily nisoldipine-CC, and hydrocholrothiazide in mild to moderate hypertension. International Journal of Clinical Practice 51(5):271-5, 1997.
  • FODOR JG, Boulet AP, Savard D, Nadeau C, Rakusan K Chockalingam A, Langer A. The role of diltiazem in treating hypertension and coronary heart disease: New approaches to preventing first events. Canadian Journal of Cardiology 13(5):495-503, 1997.
  • Joffres MR, Parviz G, FODOR JG, Petrasovits A, Chockalingam A, Hamet P. Awareness, treatment and control of hypertension in Canada. Am J of Hypertens 10:1097-1102, 1997.
  • FODOR JG, LeGrand C. Hypercholesterolemia: Diagnostic Considerations. Ateroskleroza 1(4):23-25, 1997.
  • Frohlich J, FODOR G, McPherson R, Genest J, Langner N. Rationale for and outline of the recommendations of the Working Group on Hypercholesterolemia and Other Dyslipidemias: Interim report. Can J Cardiol 14(SupplA):17A-21A, 1998.
  • FODOR JG. Patients as partners. Encouraging lifestyle changes through feedback. Canadian Family Physician 44:1207, 1998.
  • FODOR JG, van Ryn-Bolland H, Brownrigg J, LeGrand C. Cardiovascular Prevention at a Canadian Worksite. Homeostasis 38(5-6):270-1, 1998.
  • Chockalingam A, FODOR JG. Treatment of raised blood pressure in the population: The Canadian Experience. Am J of Hypertens 11:747-9, 1998.
  • FODOR G, Cutler H, Irvine J, Ramsden V, Tremblay G, Chockalingam A. Adherence to non-pharmacologic therapy for hypertension: Problems and solutions. Canadian Journal of Public Health 89(5):I-12-I-15, 1998.
  • FODOR JG, McPherson R, Dafoe WA, Grenville A. Investigation and treatment of hypercholesterolemia and other dyslipidemias in Canadian primary care practice. Journal of CVD Prevention 1(3):225-30, 1998.
  • FODOR JG. Commentary to: A model predicted the benefits of hyperlipidemia and hypertension therapy in high-risk primary prevention and secondary prevention, by SA Grover et al. Evidence-Based Medicine 3(6):194.-6, 1998.
  • Paradis, G and FODOR, J. Diet and the prevention of cardiovascular disease. Can J Cardiol 15(Suppl G):81-88, 1999.
  • Campbell NRC, Burgess E, Choi BCK, Taylor G, Wilson E, Cleroux J, FODOR JG, Leiter LA, and Spence D. Lifestyle modifications to prevent and control hypertension. 1. Methods and an overview of the Canadian recommendations Can Med Assoc J 160(9Suppl):S1-6, 1999.
  • FODOR JG, Whitmore B, Leenen F, and Larochelle P. Lifestyle modifications to prevent and control hypertension. 5. Recommendations on dietary salt. Canadian Hypertension Society Canadian Coalition for High Blood Pressure Prevention and Control, Laboratory Centre for Disease Control at Health Canada, Heart and Stroke Foundation of Canada. CMAJ 16 (Suppl 9): S29-34, 1999.
  • FODOR, JG. What Role Does the Canadian Cardiovascular Society Play in the Prevention, Clinical Practice, and Research of Disease of Circulation in Canada? Cor Vasa 42(2):71-72, 2000.
  • FODOR JG, Frohlich, JJ, Genest, J, McPherson, R. Recommendations for the management and treatment of dyslipidemia: Report of the Working Group on Hypercholesterolemia and Other Dyslipidemias. CMAJ 162(10): 1441-7, 2000.
  • Chockalingam A, FODOR JG. Ten most commonly asked questions about management of hypertension. Cardiology in Review 8(4): 189-190, 2000.
  • FODOR, JG. Prevention of Coronary Artery Disease: Identifying the Patient at Risk. Lipids in Primary Care, Fall 2000.
  • Grover SA, Dorais M, Paradis G, FODOR JG, Frohlich JJ, McPherson R, Coupal L, Zowall H. Lipid screening to prevent coronary artery disease: a quantitative evaluation of evolving guidelines. CMAJ 163(10): 1263-9, 2000.
  • FODOR JG. A nondrug, nondietary intervention to lower lipid levels? Consultations in Primary Care, 41(2): 170, February 2001.
  • FODOR, JG. Prevention of coronary artery disease: identifying the patient at risk. Asteroskleróza 5(1): 35-38, 2001.
  • McAlister FA, Levine M, Zarnke KB, Campbell N, Lewanczuk R, Leenen F, Rabkin S, Wright JM, Stone J, Feldman RD, Lebel M, Honos G, FODOR G, Burgess E, Tobe S, Hamet P, Herman R, Irvine J, Culleton B, Petrella R, Touyz R, for the Canadian Hypertension Recommendations Working Group. The 2000 Canadian recommendations for the management of hypertension: Part one – therapy. Can J Cardiol 17(5): 543-559, 2001.
  • Campbell NR, FODOR JG, Chockalingam A. Hypertension recommendations: are they relevant to public health? Can J Public Health 92(4): 245-247, 2001.
  • FODOR, JG, Adamo, K. Prevention of Type 2 Diabetes Mellitus by changes in lifestyle. Letter to the Editor. N Engl J Med 345(9): 696, 2001.
  • Joffres Michel R., Hamet Pavel, MacLean David R., L’italien Gilbert J., FODOR George: Distribution of Blood Pressure and Hypertension in Canada and the United States. American Journal of Hypertension, Ltd., 14: 1099-1105, 2001.
  • FODOR JG, Adamo, KB. Hypertension in the Elderly. Perspectives in Cardiology 17(10): 27-32, 2001.
  • FODOR JG, Adamo KB, Little D’A. The management of hypertension in the elderly. Journal of Geriatric Care Inc. 1(1): 15-23, 2002.
  • McAlister FA, Zarnke KB, Campbell NR, Feldman RD, Levine M, Mahon J, Grover SA, Lewanczuk R, Leenen F, Tobe S, Lebel M, Stone J, Schiffrin EL, Rabkin SW, Ogilvie RI, Larochelle P, Jones C, Honos G, FODOR G, Burgess E, Hamet P, Herman R, Irvine J, Culleton B, Wright JM; Canadian Hypertension Recommendations Working Group. The 2001 Canadian recommendations for the management of hypertension: Part two–Therapy. Can J Cardiol 18(6): 625-641, June 2002.
  • Reid R, FODOR G, Lydon-Hassen K et al. Dietary counselling for dyslipidemia in primary care: results of a randomized trial. Can J Diet Pract Res 63(4): 169-175, 2002 Winter.
  • FODOR JG. Hypertension in the elderly. Cardiol 12(1): 21-27, 2003.
  • FODOR GJ. Putting Your Heart at Risk: Hypertension and Dyslipidemia. Perspectives in Cardiology 19(5): 26-31, May 2003.
  • Spaans JN, Coyle D, FODOR G et al. Application of the 1998 Canadian cholesterol guidelines to a military population: Health benefits and cost effectiveness of improved cholesterol management. Can J Cardiol 19(7): 790-796, June 2003.
  • Langer A, Constance C, FODOR JG, et al. Statin therapy and the management of acute coronary syndromes. Can J Cardiol 19(8): 921-927, July 2003.
  • Genest J, Frohlich J, FODOR JG, McPherson R, on behalf of the Working Group on Hypercholesterolemia and Other Dyslipidemias. Recommendations for the management of dyslipidemia and the prevention of cardiovascular disease: summary of the 2003 update. CMAJ 169(9): 921-924, October 2003.
  • FODOR JG. Cardio Q & A: What is the optimal dose of vitamin E and ASA? Perspectives in Cardiology 20(1): 28-29, Feb 2004.
  • FODOR JG. Cardio Q & A: What would be a practical schedule for following patients on amiodarone? Perspectives in Cardiology 20(2): 20, Feb 2004.
  • FODOR G, Kotrec M. Hypertriglyceridemia: How Big is the Problem? The Canadian Journal of Diagnosis 21(4): 87-93, April 2004.
  • FODOR JG. Is there a reason to mourn the departure of the mercury sphygmomanometer? Editorial. WHL Newsletter, No. 94, April 2004.
  • FODOR JG and Tzerovska R. Coronary heart disease: is gender important? JMHG 1(1): 32-37, May 2004.
  • Plotnikoff RC, Mayhew A, Birkett N, Loucaides CA, FODOR G. Age, gender, and urban-rural differences in the correlates of physical activity. Preventive Med 39(6): 1115-1125, July 2004.
  • FODOR JG, Lietava J, Rieder A, Sonkodi S, Stokes H, Emmons T, Turton P. Work-site hypertension prevalence and control in three Central European Countries. J Hum Hypertens 18(8): 581-585, Aug 2004.
  • Sonkodi B, FODOR JG, Abraham G, Legrady P, Ondrik Z, Lencse G, Sonkodi S. Hypertension screening in a salami factory: a worksite hypertension study. J Hum Hypertens 18(8): 567-569, Aug 2004.
  • FODOR JG, Tzerovska R, Dorner T, Rieder A. Do we diagnose and treat coronary heart disease differently in men and women? Wien Med Wochenschr 154(17-18): 423-425, Sept 2004.
  • FODOR JG. The recalibration of the Framingham functions to the Chinese population improved coronary heart disease risk estimates. ACP J Club 141(3): 81, Nov/Dec 2004.
  • Genest J, McPherson R, Frohlich J, FODOR G. The analysis by Manuel and colleagues creates controversy with headlines, not data. CMAJ 172(8): 1033-1034, April 2005.
  • FODOR JG, Kotrec M, Bacskai K, Dorner T, Lietava J, Sonkodi S, Rieder A, Turton P. Is interview a reliable method to verify the compliance with antihypertensive therapy? An international central-European study. J Hypertens 23(6): 1261-1266, June 2005.
  • Khan NA, McAlister FA, Lewanczuk RZ, Touyz RM, Padwal R, Rabkin SW, Leiter LA, Herbert C, Schiffrin EL, Herman RJ, Hamet P, FODOR G, Carruthers G, Culleton B, DeChamplain J, Pylypchuk G, Logan AG, Gledhill N, Petrella R, Campbell NR, Arnold M, Moe G, Hill MD, Jones C, Larochelle P, Ogilvie RI, Tobe S, Houlden R, Burgess E, Feldman RD; Canadian Hypertension Education Program. The 2005 Canadian Hypertension Education Program recommendations for the management of hypertension: part II – therapy. Can J Cardiol 21(8): 657-672, June 2005.
  • Bourgault C, Davignon J, FODOR G, Gagné C, Gaudet D, Genest J, Lavoie M-A, Leiter L, McPherson R, Sénécal M, Marentette M, Sebaldt RJ. Statin therapy in Canadian patients with hypercholesterolemia: The Canadian Lipid Study - Observational (CALIPSO). Can J of Cardiol 21(13): 1187-1193, November 2005.
  • FODOR GJ, Kotrec M, Turton P. Novel aspects of cardiovascular prevention as of 2005. Cardiol 15(2): 89-95, March 2006.
  • Lonn E, Yusuf S, Arnold MJ, Sheridan P, Pogue J, Micks M, McQueen MJ, Probstfield J, FODOR G, Held C, Genest J Jr; Heart Outcomes Prevention Evaluation (HOPE) 2 Investigators. Homocysteine lowering with folic acid and B vitamins in vascular disease. N Engl J Med 354(15):1567-1577, April 2006.
  • Chockalingam A, Campbell NR, FODOR JG. Worldwide epidemic of hypertension. Can J Cardiol 22(7): 553-555, May 2006.
  • Khan NA, McAlister FA, Rabkin SW, Padwal R, Feldman RD, Campbell NR, Leiter LA, Lewanczuk RZ, Schiffrin EL, Hill MD, Arnold M, Moe G, Campbell TS, Herbert C, Milot A, Stone JA, Burgess E, Hemmelgarn B, Jones C, Larochelle P, Ogilvie RI, Houlden R, Herman RJ, Hamet P, FODOR G, Carruthers G, Culleton B, Dechamplain J, Pylypchuk G, Logan AG, Gledhill N, Petrella R, Tobe S, Touyz RM; Canadian Hypertension Education Program. The 2006 Canadian Hypertension Education Program recommendations for the management of hypertension: Part II - Therapy. Can J Cardiol 22(7): 583-593, May 2006.
  • McPherson R, Frohlich J, FODOR G, Genest J; Canadian Cardiovascular Society. Canadian Cardiovascular Society position statement--recommendations for the diagnosis and treatment of dyslipidemia and prevention of cardiovascular disease. Can J Cardiol 22(11): 913-927, Sept 2006. Erratum in: Can J Cardiol 22(12): 1077, Oct 2006.
  • Bosch J, Yusuf S, Gerstein HC, Pogue J, Sheridan P, Dagenais G, Diaz R, Avezum A, Lanas F, Probstfield J, FODOR G, Holman RR; DREAM Trial Investigators. Effect of ramipril on the incidence of diabetes. N Engl J Med 355(15): 1551-1562, Oct 2006.
  • Dorner T, FODOR JG, Allichhammer D, Kiefer I, Lawrence K, D’Angelo MS, Huebel U, Strunz B, Ohnoutka A, Antes G, Schmidl H, Kunze M, Rieder A. "A heart for Vienna"-- the prevention program for the big city. Blue-collar workers as a special target group. Wien Med Wochenschr 156(19-20): 552-557, Oct 2006
  • FODOR GJ, Turton P. Metabolic Syndrome: Facts and Fiction? Current Issues in Cardiac Rehabilitation and Prevention (CICRP); 14(2): 2-5, Nov 2006.
  • Khan NA, Hemmelgarn B, Padwal R, Larochelle P, Mahon JL, Lewanczuk RZ, McAlister FA, Rabkin SW, Hill MD, Feldman RD, Schiffrin EL, Campbell NR, Logan AG, Arnold M, Moe G, Campbell TS, Milot A, Stone JA, Jones C, Leiter LA, Ogilvie RI, Herman RJ, Hamet P, FODOR G, Carruthers G, Culleton B, Burns KD, Ruzicka M, Dechamplain J, Pylypchuk G, Gledhill N, Petrella R, Boulanger JM, Trudeau L, Hegele RA, Woo V, McFarlane P, Touyz RM, Tobe SW; for the Canadian Hypertension Education Program. The 2007 Canadian Hypertension Education Program recommendations for the management of hypertension: Part 2-therapy. Can J Cardiol; 23 (7): 539-550, May 2007.
  • Dorner T, FODOR JG, Lawrence K, Ludvik B, Rieder A. HDL-knowledge in the lay public: Results of a representative population survey. Atherosclerosis 2007; 195 (1): 195-198, November 2007.
  • MannJF, Sheridan P, McQueen MJ, Held C, Arnold JM, FODOR G, Yusuf S, Lonn EM; on behalf of the HOPE-2 investigators. Homocysteine lowering with folic acid and B vitamins in people with chronic kidney disease results of the renal Hope-2 study. Nephrol Dial Transplant; 23 (2): 645-653, February 2007.
  • Ray JG, Lonn E, Yi Q, Rathe A, Sheridan P, Kearon C; HOPE-2 investigators, Yusuf S, Arnold MJ, McQueen MJ, Pogue J, Probstfield J, FODOR G, Held C, Micks M, Genest J Jr. Venous thromboembolism in association with features of the metabolic syndrome. QJM; 100 (11): 679-684, November 2007.
  • FODOR JG. Primary Prevention of CVD: Treating Dyslipidaemia. BMJ Clinical Evidence; Web publication, February 2008.
  • Myers MG, McInnis NH, FODOR GJ, Leenen FHH. Comparison between an automated and manual sphygmomanometer in a population survey. Am J Hypertens; 21 (3): 280-283, March 2008.
  • Leenen FHH, Dumais j, McInnis NH, Turton P, Stratychuk L, Nemeth K, Moy Lum-Kwong M, FODOR G. Results of the Ontario Survey on the Prevalence and Control of Hypertension. CMAJ; 178 (11): 1441-1449, May 2008.
  • FODOR GJ, Leenen FHH, Helis E, Turton P. 2006 Ontario Survey on The Prevalence and Control of Hypertension (ON-BP); Rationale and Design of a Community-Based Cross-Sectional Survey. Can J Cardiol; 24 (6): 503-505, June 2008
  • FODOR G. Abdominal Obesity: A Physician’s ‘Supertool’ for Accessing CVD Risk. Patient Care Cardiology (Medical Post); June 24, 2008
  • Myers Mg, McInnis NH, FODOR GJ, Leenen FH. Response to “automated sphygmomanometers should not replace manual ones, based on current evidence”. Am J Hypertens 2008; 21 (8): 846, August 2008
  • McInnis NH, FODOR G, Moy Lum-Kwong M, Leenen FH. Antihypertensive Medication Use and Blood Pressure Control: A Community-Based Cross-Sectional Survey (ON-BP). Am J Hypertens 2008; September 4 (in press)

BOOK CHAPTERS

  • A Táplálkozás Egészségkonyve, Kossuth Kiadó publishing house, 2000 Budapest

Share This